Kim Jin You, Partridge Savannah C
Department of Radiology and Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea.
Department of Radiology, University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA.
Radiol Clin North Am. 2024 Jul;62(4):661-678. doi: 10.1016/j.rcl.2023.12.009. Epub 2024 Mar 7.
Considering the high cost of dynamic contrast-enhanced MR imaging and various contraindications and health concerns related to administration of intravenous gadolinium-based contrast agents, there is emerging interest in non-contrast-enhanced breast MR imaging. Diffusion-weighted MR imaging (DWI) is a fast, unenhanced technique that has wide clinical applications in breast cancer detection, characterization, prognosis, and predicting treatment response. It also has the potential to serve as a non-contrast MR imaging screening method. Standardized protocols and interpretation strategies can help to enhance the clinical utility of breast DWI. A variety of other promising non-contrast MR imaging techniques are in development, but currently, DWI is closest to clinical integration, while others are still mostly used in the research setting.
考虑到动态对比增强磁共振成像的高成本以及与静脉注射钆基对比剂相关的各种禁忌症和健康问题,非对比增强乳腺磁共振成像正越来越受到关注。扩散加权磁共振成像(DWI)是一种快速、无需增强的技术,在乳腺癌检测、特征分析、预后评估以及预测治疗反应方面具有广泛的临床应用。它还有潜力作为一种非对比磁共振成像筛查方法。标准化方案和解读策略有助于提高乳腺DWI的临床应用价值。多种其他有前景的非对比磁共振成像技术正在研发中,但目前,DWI最接近临床应用,而其他技术大多仍用于研究领域。